BioCardia enrolls first patient at University of Wisconsin in phase 3 trial
Tweet Send to a Friend
BioCardia Inc. (NASDAQ: BCDA) announced that the University of Wisconsin School of Medicine and Public Health has enrolled its first ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


